Jiao D, Sun X, Qiao J, Jia H, et al. Efficacy and safety of camrelizumab plus docetaxel and carboplatin as neoadjuvant therapy for stage II-III triple-negative breast cancer: the HELEN-Trio 011 randomized clinical trial. Ann Oncol 2026 Oct 16:S0923-7534(26)06884-5. doi: 10.1016/j.annonc.2026.
PMID: 42887596